The Consumers Federation of Kenya (COFEK), the nation’s leading consumer advocacy group, has initiated Constitutional Petition HCCHRPET/E518/2026, bringing the Kenya Nutritionists and Dieticians Institute (KNDI), Weetabix East Africa, Brookside Dairy, and the Ministry of Health before the High Court. The dispute centers on a green “KNDI Endorsed” label appearing on cereal and dairy products across Kenya.
Central Claim
COFEK’s position is clear: KNDI, established under the Nutritionists and Dieticians Act, is tasked with training, registering, licensing, and disciplining nutrition professionals. It lacks authority over food labeling or product certification. This role falls under the Kenya Bureau of Standards (KEBS), which issues the Diamond Mark. KEBS has been joined as an Interested Party, as the case hinges on jurisdictional boundaries. COFEK argues the “KNDI Endorsed” label mimics KEBS’s official mark, misleading consumers into believing it carries government approval. In reality, the scheme lacks legal foundation, with no supporting Act, gazette notice, or statutory instrument. Weetabix reportedly obtained this endorsement in March 2023, with KNDI collecting fees from participating manufacturers while ignoring similar products without the label.
Sequence of Events
COFEK pursued non-judicial avenues before filing suit. On July 15, it wrote to Health Cabinet Secretary Aden Duale, demanding an audit of all products bearing the mark. On July 21, it asked Weetabix to remove the label and disclose payments. Duale responded on July 22, directing KNDI’s CEO to justify the mark’s legality within seven days. KNDI countered on July 23, citing a “97.35 percent wholesomeness score” and threatening to sue COFEK for harassment. Weetabix’s lawyers rejected the demand on July 30. With no resolution, COFEK filed suit on August 3. Justice Gregory Mutai granted an urgent hearing during the court’s August recess—an uncommon procedural move—with a compliance mention set for September 24, 2026.
Read Also: Kenya Bureau of Standards faces big deficit
Petition Demands
The petition includes 13 requests, such as declaring the endorsement scheme unconstitutional and ultra vires, issuing an order of certiorari to nullify it, and injunctions preventing KNDI from further endorsements and Weetabix/Brookside from claiming official approval. It also seeks a government-wide review of product endorsement frameworks. Additionally, COFEK highlights that KNDI’s CEO has served nearly two decades, exceeding the four-year renewable term, and requests an Auditor-General review of KNDI’s finances.
Broader Implications
This case highlights a recurring issue in Kenyan regulatory governance: statutory bodies engaging in commercially lucrative activities beyond their mandates, with consumers bearing the cost through higher prices tied to “endorsement fees” disguised as scientific validation. Kenya is not unique in addressing deceptive endorsements. Comparative frameworks offer insight. The U.S. Federal Trade Commission’s Endorsement Guides mandate that endorsements implying regulatory or expert approval must be truthful, substantiated, and non-misleading as to the endorser’s actual authority.
The EU’s Unfair Commercial Practices Directive prohibits traders from falsely claiming approval from public or private bodies. Kenya’s Consumer Protection Act includes similar provisions (Sections 12 and 13) but lacks a dedicated advertising regulator with swift enforcement powers, necessitating a constitutional petition rather than an administrative resolution. This regulatory gap is the case’s underlying issue.
Leave a Reply